Theracryf (TCF) Competitors GBX 0.25 0.00 (0.00%) As of 09/12/2025 10:25 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsBuy This Stock TCF vs. HARL, SOS, VEL, ING, SPO, NWT, IX, TREE, STL, and HWCShould you be buying Theracryf stock or one of its competitors? The main competitors of Theracryf include Harland & Wolff Group (HARL), Sosandar (SOS), Velocity Composites (VEL), Ingenta (ING), Sportech (SPO), Newmark Security (NWT), i(x) Net Zero (IX), Cambium Global Timberland (TREE), Stilo International (STL), and Highway Capital (HWC). These companies are all part of the "banking" industry. Theracryf vs. Its Competitors Harland & Wolff Group Sosandar Velocity Composites Ingenta Sportech Newmark Security i(x) Net Zero Cambium Global Timberland Stilo International Highway Capital Harland & Wolff Group (LON:HARL) and Theracryf (LON:TCF) are both small-cap banking companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, institutional ownership, valuation, profitability, risk, analyst recommendations, dividends and media sentiment. Does the media refer more to HARL or TCF? In the previous week, Harland & Wolff Group's average media sentiment score of 0.00 equaled Theracryf'saverage media sentiment score. Company Overall Sentiment Harland & Wolff Group Neutral Theracryf Neutral Which has more risk and volatility, HARL or TCF? Harland & Wolff Group has a beta of 3.14, meaning that its stock price is 214% more volatile than the S&P 500. Comparatively, Theracryf has a beta of 1.42, meaning that its stock price is 42% more volatile than the S&P 500. Do insiders and institutionals believe in HARL or TCF? 60.8% of Harland & Wolff Group shares are held by institutional investors. Comparatively, 7.8% of Theracryf shares are held by institutional investors. 16.3% of Harland & Wolff Group shares are held by insiders. Comparatively, 22.7% of Theracryf shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Which has preferable earnings & valuation, HARL or TCF? Theracryf has lower revenue, but higher earnings than Harland & Wolff Group. Theracryf is trading at a lower price-to-earnings ratio than Harland & Wolff Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHarland & Wolff Group£86.91M0.00-£43.09M-£0.24N/ATheracryfN/AN/A-£5.45M-£0.00-69.44 Is HARL or TCF more profitable? Harland & Wolff Group has a net margin of -49.57% compared to Theracryf's net margin of -792.17%. Harland & Wolff Group's return on equity of 0.00% beat Theracryf's return on equity.Company Net Margins Return on Equity Return on Assets Harland & Wolff Group-49.57% N/A -16.78% Theracryf -792.17%-99.97%-48.26% SummaryHarland & Wolff Group beats Theracryf on 7 of the 10 factors compared between the two stocks. Get Theracryf News Delivered to You Automatically Sign up to receive the latest news and ratings for TCF and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TCF vs. The Competition Export to ExcelMetricTheracryfBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£5.37M£153.68M£5.84B£2.51BDividend YieldN/A3.78%5.68%5.30%P/E Ratio-69.4441.0875.415,410.94Price / SalesN/A4,942.15515.8196,613.70Price / CashN/A13.1937.5627.93Price / Book0.29103.7512.157.77Net Income-£5.45M-£90.99M£3.29B£5.89B7 Day Performance1.21%2.86%0.73%6.51%1 Month Performance9.17%21.20%4.99%55.22%1 Year Performance-64.03%526.77%62.53%154.12% Theracryf Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TCFTheracryfN/AGBX 0.25flatN/A-64.0%£5.37MN/A-69.4410Gap UpHigh Trading VolumeHARLHarland & Wolff GroupN/AN/AN/AN/A£14.49M£86.91M-34.9081News CoverageSOSSosandarN/AGBX 5.02-8.7%N/A-49.3%£12.47M£37.13M-2,282.73170Gap DownVELVelocity Composites1.1163 of 5 starsGBX 20.74+2.1%GBX 60+189.3%-53.0%£11.34M£22.70M-1,513.87102Gap DownINGIngentaN/AGBX 61.48+0.8%N/A-47.8%£8.92M£10.20M714.8865,000SPOSportechN/AN/AN/AN/A£8.40M£26.98M-1,680.00217,000Gap UpHigh Trading VolumeNWTNewmark SecurityN/AGBX 77.40-14.0%N/A-2.3%£7.26M£22.13M-2,856.09102Positive NewsGap DownIXi(x) Net ZeroN/AN/AN/AN/A£6.99M£80.05M14.8132,200Gap UpHigh Trading VolumeTREECambium Global TimberlandN/AN/AN/AN/A£4.98M£4.57B11.271,250Gap DownHigh Trading VolumeSTLStilo InternationalN/AN/AN/AN/A£3.42M£1.42M30.001,907Gap UpHWCHighway CapitalN/AN/AN/AN/A£1.78MN/A0.003,630Gap Up Related Companies and Tools Related Companies HARL Competitors SOS Competitors VEL Competitors ING Competitors SPO Competitors NWT Competitors IX Competitors TREE Competitors STL Competitors HWC Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:TCF) was last updated on 9/14/2025 by MarketBeat.com Staff From Our PartnersTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredExpert Alert: Massive Bubble Could Crash Your WealthOn July 4th, Trump signed the “One Big Beautiful Bill,” adding $3.4 trillion to the national debt — and pushin...American Alternative | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredChina’s message to TrumpDid China just fire shots at America? Last week, in Tiananmen Square, China put on a chilling display of mi...Porter & Company | Sponsored$15 Fund: Turn Gold Boom into Real IncomeIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredThe $17B signal no one expected…After SpaceX struck a $17 billion deal with EchoStar for a block of radio frequencies, tech analyst Jeff Brown...Brownstone Research | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Theracryf Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Theracryf With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.